SCHEMBL4907699

SCHEMBL4907699

COCCCCC1(CNC(=O)[C@H]2C[C@@H](C(=O)NCCC(C)O)CN(C(=O)OC(C)(C)C)C2)c2ccccc2Oc2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
REN P00797 4/20 0.54
MAPT P10636 1/20 0.34
NAMPT P43490 1/20 0.33
GPR119 Q8TDV5 1/20 0.32
MAPK1 P28482 1/20 0.32
PDE4B Q07343 1/20 0.32
USP30 Q70CQ3 1/20 0.31
KDM4E B2RXH2 3/20 0.31
PKM P14618 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
IL1B P01584 1/20 0.31
P2RX7 Q99572 1/20 0.31
PRMT5 O14744 1/20 0.31
WDR77 Q9BQA1 1/20 0.31
KMT2A Q03164 1/20 0.31
GAA P10253 1/20 0.31
KDM4C Q9H3R0 1/20 0.31
TLR2 O60603 1/20 0.31
TLR1 Q15399 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4912112 1.00 REN (0.54) RENMAPTNAMPTGPR119MAPK1
SCHEMBL4907695 1.00 REN (0.54) RENMAPTNAMPTGPR119MAPK1
SCHEMBL14089230 1.00 REN (0.54) RENMAPTNAMPTGPR119MAPK1
SCHEMBL4910052 0.95 REN (0.54) RENMAPTNAMPTMAPK1USP30
SCHEMBL4910054 0.95 REN (0.54) RENMAPTNAMPTMAPK1USP30
SCHEMBL4910192 0.95 REN (0.54) RENMAPTNAMPTMAPK1USP30
SCHEMBL4909883 0.91 REN (0.55) RENMAPTNAMPTMAPK1USP30
SCHEMBL4902242 0.91 REN (0.55) RENMAPTNAMPTGPR119USP30
SCHEMBL4909887 0.91 REN (0.55) RENMAPTNAMPTMAPK1USP30
SCHEMBL4911876 0.91 REN (0.57) RENMAPTNAMPTMAPK1USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194629-A1 3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors BAESCHLIN DANIEL KASPAR 2008-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194629-A1 3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors REN, ACE, AGTR1 REN 1/4885MAPT 1706/4885NAMPT 2165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.